Amgen | AMGN

Stock Price
220.65
Daily Change
0.97%
Yearly
-12.93%
Q2 Forecast
210.68
Rating
Sell

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
Takeda 4,421.00 -121.00 -2.66% 19.04%
AbbVie 137.96 1.52 1.11% -5.52%
Agios Pharmaceuticals 25.28 -0.04 -0.16% 32.43%
ALKERMES 28.93 -0.25 -0.86% -3.47%
Amgen 220.65 2.12 0.97% -12.93%
Biogen 296.41 -2.28 -0.76% 48.21%
Bluebird Bio 3.35 0.04 1.21% 12.79%
BioMarin Pharmaceutical 86.94 -0.28 -0.32% 16.90%
Bristol-Myers Squibb 64.44 0.73 1.15% -14.16%
Coherus Biosciences 4.09 -0.06 -1.45% -44.43%
Exelixis 19.28 0.27 1.42% 4.39%
Genmab 2,725.00 -21.00 -0.76% 30.76%
Gilead Sciences 76.94 0.61 0.80% 18.79%
GlaxoSmithKline 1,346.40 -24.60 -1.79% -21.16%
Glaxosmithkline 33.60 -0.26 -0.77% -21.93%
Intercept Pharmaceuticals 10.54 -0.23 -2.14% -40.92%
Incyte Corp 61.55 -0.32 -0.52% -17.91%
Ionis Pharmaceuticals 40.90 0.35 0.86% 13.90%
J&J 155.06 0.69 0.45% -12.75%
Eli Lilly 429.46 2.22 0.52% 42.00%
Merck & Co 110.41 1.24 1.14% 21.14%
Moderna 127.71 -1.18 -0.92% -10.94%
Mirati Therapeutics 37.16 0.06 0.16% -6.94%
Neurocrine Biosciences 89.53 -0.58 -0.64% -3.47%
Novartis 87.16 0.14 0.16% 1.14%
Novartis 96.25 -0.30 -0.31% 7.37%
Puma Biotechnology 3.35 0.08 2.45% 79.14%
Pfizer 38.02 1.01 2.73% -27.40%
PTC Therapeutics 41.97 0.81 1.97% 44.33%
Ultragenyx Pharmaceutical 49.36 0.95 1.96% 6.98%
Regeneron Pharmaceuticals 735.56 6.96 0.96% 16.63%
Roche Holding 288.20 0.30 0.10% -10.69%
Sanofi 94.88 0.57 0.60% -4.60%
Seattle Genetics 195.70 1.69 0.87% 45.87%
Sarepta Therapeutics 123.60 -1.22 -0.98% 70.25%
Teva Pharmaceutical Industries 2,680.00 -89.00 -3.21% -11.90%
Vertex Pharmaceuticals 323.57 -1.73 -0.53% 19.82%

Indexes Price Day Year
US500 4186 -25.69 -0.61% 0.22%
USND 12935 -82.14 -0.63% 7.84%
USNDX 14273 -100.90 -0.70% 10.70%
US30 32883 -134.51 -0.41% -1.10%

Amgen

Amgen traded at $220.65 this Wednesday May 31st, increasing $2.12 or 0.97 percent since the previous trading session. Looking back, over the last four weeks, Amgen gained 7.64 percent. Over the last 12 months, its price fell by 12.93 percent. Looking ahead, we forecast Amgen to be priced at 210.68 by the end of this quarter and at 193.00 in one year, according to Trading Economics global macro models projections and analysts expectations.

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes ENBREL, Prolia (denosumab), Neulasta (pegfilgrastim), Otezla, XGEVA, Aranesp (darbepoetin alfa), KYPROLIS, Repatha (evolocumab), Nplate (romiplostim), Vectibix (panitumumab), MVASI (bevacizumab-awwb), Parsabiv (etelcalcetide), EPOGEN (epoetin alfa), KANJINTI (trastuzumab-anns), BLINCYTO (blinatumomab), Aimovig (erenumab-aooe), EVENITY (romosozumab-aqqg), AMGEVITATM (adalimumab), Sensipar/Mimpara (cinacalcet), NEUPOGEN (filgrastim), IMLYGIC (talimogene laherparepvec), Corlanor (ivabradine) and AVSOLA (infliximab-axxq). It focuses on human therapeutics for the treatment of serious illness in the areas of inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience.